Aryl sulfonic pyridoxines as antiplatelet agents

Details Aryl sulfonic pyridoxines as antiplatelet agents Aryl sulfonic pyridoxines as antiplatelet agents

2004-10-28

2008-12-02

Davis, Zinna N (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S302000, C514S352000, C514S357000, C546S115000, C546S290000, C546S304000, C546S329000, C546S339000

Reexamination Certificate

active

07459468

ABSTRACT:
Aryl sulfonic pyridoxine compounds with antiplatelet aggregation characteristics for the treatment of cardiovascular and cardiovascular related disease, are described. The methods are directed to administering pharmaceutical compositions comprising aryl sulfonic pyridoxines.

REFERENCES:
patent: 3206463 (1965-09-01), Baetz
patent: 3227721 (1966-01-01), Pfister, III et al.
patent: 3227724 (1966-01-01), Firestone et al.
patent: 3282778 (1966-11-01), Lobel
patent: 3632806 (1972-01-01), Ichizo et al.
patent: 3910921 (1975-10-01), Esanu
patent: 3987177 (1976-10-01), Giudicelli et al.
patent: 4012377 (1977-03-01), Claisse et al.
patent: 4032534 (1977-06-01), Chodkiewicz
patent: 4036844 (1977-07-01), Thorne et al.
patent: 4053607 (1977-10-01), Thorne et al.
patent: 4137316 (1979-01-01), Esanu
patent: 4167562 (1979-09-01), Evers
patent: 4237118 (1980-12-01), Howard
patent: 4361570 (1982-11-01), Fici
patent: 4369172 (1983-01-01), Schor et al.
patent: 4374841 (1983-02-01), Descamps et al.
patent: 4515771 (1985-05-01), Fine
patent: 4567179 (1986-01-01), Lombardino
patent: 4569938 (1986-02-01), Esanu
patent: 4569939 (1986-02-01), Esanu
patent: 4581363 (1986-04-01), Esanu
patent: 4605741 (1986-08-01), Zagnoli et al.
patent: 4696920 (1987-09-01), Bentzen et al.
patent: 4730042 (1988-03-01), Hege et al.
patent: 4735950 (1988-04-01), Esanu
patent: 4735956 (1988-04-01), Baldwin et al.
patent: 4837239 (1989-06-01), Benjamin et al.
patent: 4843071 (1989-06-01), Hohenwarter
patent: 4898879 (1990-02-01), Madsen et al.
patent: 4962121 (1990-10-01), Hamberger et al.
patent: 5001115 (1991-03-01), Sloan
patent: 5053396 (1991-10-01), Blass
patent: 5118505 (1992-06-01), Költringer
patent: 5130311 (1992-07-01), Guillaumet et al.
patent: 5130324 (1992-07-01), Ulrich et al.
patent: 5132115 (1992-07-01), Wolter et al.
patent: 5155116 (1992-10-01), Guillaumet et al.
patent: 5210083 (1993-05-01), Pfirrmann
patent: 5213813 (1993-05-01), Kornecki et al.
patent: 5254557 (1993-10-01), Buckle et al.
patent: 5254572 (1993-10-01), Serfontein
patent: 5272165 (1993-12-01), Ulrich et al.
patent: 5278154 (1994-01-01), Lacoste et al.
patent: 5288716 (1994-02-01), Speck
patent: 5326757 (1994-07-01), Demopoulos
patent: 5328453 (1994-07-01), Sibalis
patent: 5372999 (1994-12-01), Schneider et al.
patent: 5385937 (1995-01-01), Stamler et al.
patent: 5420112 (1995-05-01), Lewis et al.
patent: 5441972 (1995-08-01), Ogata et al.
patent: 5504090 (1996-04-01), Neely
patent: 5563126 (1996-10-01), Allen et al.
patent: 5569459 (1996-10-01), Shlyankevich
patent: 5569648 (1996-10-01), Lewis et al.
patent: 5594004 (1997-01-01), Katano et al.
patent: 5631271 (1997-05-01), Serfontein
patent: 5633228 (1997-05-01), Lewis et al.
patent: 5648335 (1997-07-01), Lewis et al.
patent: 5728684 (1998-03-01), Cheng et al.
patent: 5733884 (1998-03-01), Barbul et al.
patent: 5733916 (1998-03-01), Neely
patent: 5770215 (1998-06-01), Moshyedi
patent: 5795873 (1998-08-01), Allen
patent: 5804163 (1998-09-01), Gibby et al.
patent: 5804594 (1998-09-01), Murad
patent: 5833998 (1998-11-01), Biedermann et al.
patent: 5834446 (1998-11-01), Dow et al.
patent: 5840685 (1998-11-01), Fujii et al.
patent: 5847008 (1998-12-01), Doebber et al.
patent: 5858017 (1999-01-01), Demopulos et al.
patent: 5859051 (1999-01-01), Adams et al.
patent: 5874420 (1999-02-01), Pelleg
patent: 5874443 (1999-02-01), Kiely et al.
patent: 5888514 (1999-03-01), Weisman
patent: 5944020 (1999-08-01), Markov et al.
patent: 6043259 (2000-03-01), Dhalla et al.
patent: 6051587 (2000-04-01), Dakashinamurti et al.
patent: 6066659 (2000-05-01), Speck
patent: 6121249 (2000-09-01), Weissman et al.
patent: 6274170 (2001-08-01), Heibel et al.
patent: 6323188 (2001-11-01), Weissman
patent: 6339085 (2002-01-01), Haque
patent: 6358960 (2002-03-01), Senokuchi et al.
patent: 6417204 (2002-07-01), Haque
patent: 6489345 (2002-12-01), Sethi
patent: 6544547 (2003-04-01), Hageman
patent: 6548519 (2003-04-01), Haque
patent: 6586414 (2003-07-01), Haque et al.
patent: 6605612 (2003-08-01), Haque
patent: 6667315 (2003-12-01), Haque
patent: 6677356 (2004-01-01), Sethi et al.
patent: 6780997 (2004-08-01), Haque
patent: 6861439 (2005-03-01), Haque et al.
patent: 6867215 (2005-03-01), Haque
patent: 6890943 (2005-05-01), Haque
patent: 6897228 (2005-05-01), Haque
patent: 7105673 (2006-09-01), Haque
patent: 7115625 (2006-10-01), Sethi et al.
patent: 7115626 (2006-10-01), Sethi et al.
patent: 7125889 (2006-10-01), Sethi et al.
patent: 7132430 (2006-11-01), Sethi et al.
patent: 7144892 (2006-12-01), Sethi et al.
patent: 7148233 (2006-12-01), Sethi et al.
patent: 7230009 (2007-06-01), Haque et al.
patent: 2003/0114424 (2003-06-01), Haque et al.
patent: 2004/0121988 (2004-06-01), Haque et al.
patent: 2004/0171588 (2004-09-01), Haque
patent: 2004/0186077 (2004-09-01), Diakur et al.
patent: 2004/0235907 (2004-11-01), Sethi
patent: 2005/0107443 (2005-05-01), Haque
patent: 2006/0019929 (2006-01-01), Friesen
patent: 2006/0035864 (2006-02-01), Friesen
patent: 2006/0094749 (2006-05-01), Haque et al.
patent: 2006/0094761 (2006-05-01), Haque et al.
patent: 2006/0148763 (2006-07-01), Friesen et al.
patent: 2006/0241083 (2006-10-01), Diakur et al.
patent: 2007/0032456 (2007-02-01), Friesen
patent: 2007/0060549 (2007-03-01), Friesen
patent: 2007/0142270 (2007-06-01), Haque et al.
patent: 2007/0149485 (2007-06-01), Friesen
patent: 2007/0167411 (2007-07-01), Reimer
patent: 2007/0243249 (2007-10-01), Reimer
patent: 2007/0249562 (2007-10-01), Reimer
patent: 831350 (1976-01-01), None
patent: 863754 (1978-05-01), None
patent: 933 522 (1973-09-01), None
patent: 561 183 (1975-04-01), None
patent: 24 61 742 (1976-07-01), None
patent: 43 44 751 (1995-06-01), None
patent: 0 121 036 (1984-10-01), None
patent: 0 144 051 (1985-06-01), None
patent: 0 270 026 (1988-06-01), None
patent: 0 416 248 (1991-03-01), None
patent: 0 891 719 (1999-01-01), None
patent: 5552 (1967-12-01), None
patent: 5801 (1968-03-01), None
patent: 6453 (1968-12-01), None
patent: 2101010 (1972-03-01), None
patent: 2255883 (1975-07-01), None
patent: 2428640 (1980-01-01), None
patent: 1 013 939 (1965-12-01), None
patent: 1 201 014 (1970-08-01), None
patent: 1 248 324 (1972-02-01), None
patent: 1 297 080 (1972-11-01), None
patent: 1 360 536 (1974-07-01), None
patent: 1 597 428 (1981-09-01), None
patent: 2 254 556 (1992-10-01), None
patent: 48-21959 (1973-07-01), None
patent: 54-17130 (1979-02-01), None
patent: 10-158244 (1998-06-01), None
patent: 2000-26295 (2000-01-01), None
patent: WO 91/19500 (1991-12-01), None
patent: WO 94/18965 (1994-09-01), None
patent: WO 97/30047 (1997-08-01), None
patent: WO 98/28310 (1998-07-01), None
patent: WO 02/04421 (2002-01-01), None
patent: WO 02/34711 (2002-05-01), None
patent: WO 2005/060975 (2005-07-01), None
patent: WO 2005/070889 (2005-08-01), None
patent: WO 2006/005173 (2006-01-01), None
patent: WO 2006/026868 (2006-03-01), None
patent: WO 2006/056079 (2006-06-01), None
patent: WO 2006/058411 (2006-06-01), None
patent: WO 2006/102748 (2006-10-01), None
patent: WO 2006/136004 (2006-12-01), None
Doktorowa et al, Tetrahedron, 1969, vol. 25, No. 16, pp. 3527-3553.
Arbuzov, S., “Pharmacological Properties of the Products of the Condensation of Phenamine with Some Metabolites”,Farmakol. Toksikol, vol. 31, No. 3, pp. 373-376 (1968) (Abstract only).
Aybak, M. et al., “Effect of Oral Pyridoxine Hydrochloride Supplementation on Arterial Blood Pressure with Essential Hypertension”,Drug Res., vol. 45, No. 12, pp. 1271-1273 (1995).
“B Vitamins May Cut Heart Disease Risk”,Harvard Health Letter, 1 page (1998).
Baliga, B. et al., “Hyperhomocysteinemia in Type 2 Disbetes Mellitus: Cardiovascular Risk Factors and Effect of Treatment with Folic Acid and Pyridoxine”,Endocrine Practice, vol. 6, No. 6, pp. 435-441 (Nov./Dec. 2000).
Barrett, S., “Homocysteine: A Cardiovascular Risk Factor Worth Considering”, http://www.quackwatch.com/03HealthPromotion/homocysteine.html, 2 pages (1997).
Bennett, R. et al., “Vitamin B6-Phosphonic Acids”,Journal of Medicinal and Pharmaceutical Chemi

Affiliated with

Also associated with

Rating

Aryl sulfonic pyridoxines as antiplatelet agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl sulfonic pyridoxines as antiplatelet agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl sulfonic pyridoxines as antiplatelet agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4022351